105 Results

People

  1. Giralt
    Giralt
  2. Perales
    Perales
  3. Jakubowski
    Jakubowski
  4. Papadopoulos
    Papadopoulos
  5. O'Reilly
    O'Reilly
  6. Kernan
    Kernan
  7. Castro-Malaspina
    Castro-Malaspina
  8. Barker
    Barker
  9. Scaradavou
    Scaradavou
  10. Young
    Young

Groups

  1. Department of Medicine (72)
  2. Center for Hematologic Malignancies (65)
  3. Hematologic Malignancies, Division of (60)
  4. Bone Marrow Transplant (54)
  5. Pediatrics, Department of (52)
  6. Stem Cell Transplantation and Cellular Therapy Service (42)
  7. Survivorship Research (32)
  8. GSK Faculty (30)
  9. Tow Center for Developmental Oncology (TCDO) (29)
  10. Sloan Kettering Institute Faculty (22)
  1. "myeloablative conditioning"
Formats
  1. Journal Article (93)
  2. Research Letter (4)
  3. Editorial (3)
  4. Conference Paper (2)
  5. Guidelines (2)
  6. Review (1)
Groups
  1. Department of Medicine (72)
  2. Center for Hematologic Malignancies (65)
  3. Hematologic Malignancies, Division of (60)
  4. Bone Marrow Transplant (54)
  5. Pediatrics, Department of (52)
  6. Stem Cell Transplantation and Cellular Therapy Service (42)

More Groups

People
  1. Sergio Giralt (26)
  2. Miguel-Angel Perales (24)
  3. Juliet Barker (20)
  4. Ann Jakubowski (19)
  5. Esperanza Papadopoulos (18)
  6. Richard O'Reilly (16)

More People

Years
  1. 2025 (4)
  2. 2024 (5)
  3. 2023 (8)
  4. 2022 (5)
  5. 2021 (2)
  6. 2020 (9)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (33)
  2. Blood (13)
  3. Bone Marrow Transplantation (13)
  4. Pediatric Blood and Cancer (5)
  5. Transplantation and Cellular Therapy (5)
  6. Blood Advances (4)

More Publications

Publishers
  1. Elsevier Inc. (44)
  2. American Society of Hematology (17)
  3. Nature Publishing Group (16)
  4. Wiley Periodicals, Inc (5)
  5. John Wiley & Sons (4)
  6. Wiley Blackwell (4)

More Publishers

Results (105)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD–mutated AML
    Journal Article

    Levis, M. J.; Hamadani, M.; Logan, B. R.; Jones, R. J.; Singh, A. K.; Litzow, M. R.; Wingard, J. R.; Papadopoulos, E. B.; Perl, A. E.; Soiffer, R. J.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • Bodyweight and absolute lymphocyte count-based dosing of rabbit anti-thymocyte globulin results in early CD4+ immune reconstitution in patients with inborn errors of metabolism undergoing umbilical cord blood transplantation
    Journal Article

    Drozdov, D.; Kandil, J.; Long, S. E.; Demorest, C. V.; Cao, Q.; Lund, T. C.; Gupta, A. O.; Boelens, J. J.; Orchard, P. J.
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • The adverse event landscape of stem cell transplant: Evidence for AGVHD driving early transplant associated toxicities
    Journal Article

    Takahashi, T.; Watkins, B.; Bratrude, B.; Neuberg, D.; Hebert, K.; Betz, K.; Yu, A.; Choi, S. W.; Davis, J.; Duncan, C.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on pediatric chronic graft-versus-host disease survivorship after hematopoietic cell transplantation: Part I. Phases of chronic GVHD, supportive care, and systemic therapy discontinuation
    Journal Article

    Bhatt, N. S.; Harris, A. C.; Gorfinkel, L.; Ibanez, K.; Tkaczyk, E. R.; Mitchell, S. A.; Albuquerque, S.; Schechter, T.; Pavletic, S.; Duncan, C. N.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • High-dose individualized antithymocyte globulin with therapeutic drug monitoring in high-risk cord blood transplant
    Journal Article

    Admiraal, R.; Versluijs, A. B.; Huitema, A. D. R.; Ebskamp, L.; Lacna, A.; de Kanter, C. T. K.; Bierings, M. B.; Boelens, J. J.; Lindemans, C. A.; Nierkens, S.
    Cytotherapy (2024)

    Fulltext@MSK | Save
  • Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHD
    Journal Article

    Gorfinkel, L.; Raghunandan, S.; Watkins, B.; Hebert, K.; Neuberg, D. S.; Bratrude, B.; Betz, K.; Yu, A.; Choi, S. W.; Davis, J.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Gilteritinib as post-transplant maintenance for AML with internal tandem duplication mutation of FLT3
    Journal Article

    Levis, M. J.; Hamadani, M.; Logan, B.; Jones, R. J.; Singh, A. K.; Litzow, M.; Wingard, J. R.; Papadopoulos, E. B.; Perl, A. E.; Soiffer, R. J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Outcomes and management of the SARS-CoV2 omicron variant in recipients of hematopoietic cell transplantation and chimeric antigen receptor T cell therapy
    Journal Article

    Infante, M. S.; Nemirovsky, D.; Devlin, S.; DeWolf, S.; Tamari, R.; Dahi, P. B.; Lee, Y. J.; Chung, D. J.; Politikos, I.; Barker, J.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • HHV-6B detection and host gene expression implicate HHV-6B as pulmonary pathogen after hematopoietic cell transplant
    Journal Article

    Hill, J. A.; Lee, Y. J.; Vande Vusse, L. K.; Xie, H.; Chung, E. L.; Waghmare, A.; Cheng, G. S.; Zhu, H.; Huang, M. L.; Hill, G. R.; more...
    Nature Communications (2024)

    Fulltext@MSK | Save
  • Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: Final report of BMT CTN 2002
    Research Letter

    Meyers, G.; Hamadani, M.; Martens, M.; Ali, H.; Chevallier, P.; Choe, H.; Harris, A. C.; Holler, E.; van Hooren, E.; Klaassen, W.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save